Traws Pharma, Inc. (TRAW) stock
TRAWNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.24+0.01 (+3.94%)
Close on Nov 18, 2026Market cap $3.73MP/E –Yield –
Traws Pharma revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Traws Pharma's revenue for the twelve months ending Dec 31, 2025 was $2.79M, up 1134.5% year over year. For fiscal 2025 it was $2.79M, up 1134.5% from the year before. Over ten years it grew -13.2% a year on average. The highest annual figure on record is $46.19M in fiscal 2012.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.79M | +1134.5% |
| FY2024 | Dec 31, 2024 | $226.00K | 0.0% |
| FY2023 | Dec 31, 2023 | $226.00K | 0.0% |
| FY2022 | Dec 31, 2022 | $226.00K | 0.0% |
| FY2021 | Dec 31, 2021 | $226.00K | -2.2% |
| FY2020 | Dec 31, 2020 | $231.00K | -89.4% |
| FY2019 | Dec 31, 2019 | $2.18M | +77.8% |
| FY2018 | Dec 31, 2018 | $1.23M | +56.0% |
| FY2017 | Dec 31, 2017 | $787.00K | -85.8% |
| FY2016 | Dec 31, 2016 | $5.55M | -51.6% |
| FY2015 | Dec 31, 2015 | $11.46M | +1332.0% |
| FY2014 | Dec 31, 2014 | $800.00K | -83.2% |
| FY2013 | Dec 31, 2013 | $4.75M | -89.7% |
| FY2012 | Dec 31, 2012 | $46.19M | +3006.3% |
| FY2011 | Dec 31, 2011 | $1.49M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2025 | Dec 31, 2025 | $0 | -100.0% |
| Q3 FY2025 | Sep 30, 2025 | $0 | -100.0% |
| Q2 FY2025 | Jun 30, 2025 | $2.73M | +4694.7% |
| Q1 FY2025 | Mar 31, 2025 | $57.00K | +1.8% |
| Q4 FY2024 | Dec 31, 2024 | $56.00K | 0.0% |
| Q3 FY2024 | Sep 30, 2024 | $57.00K | 0.0% |
| Q2 FY2024 | Jun 30, 2024 | $57.00K | 0.0% |
| Q1 FY2024 | Mar 31, 2024 | $56.00K | 0.0% |
| Q4 FY2023 | Dec 31, 2023 | $56.00K | 0.0% |
| Q3 FY2023 | Sep 30, 2023 | $57.00K | 0.0% |
| Q2 FY2023 | Jun 30, 2023 | $57.00K | 0.0% |
| Q1 FY2023 | Mar 31, 2023 | $56.00K | 0.0% |
| Q4 FY2022 | Dec 31, 2022 | $56.00K | 0.0% |
| Q3 FY2022 | Sep 30, 2022 | $57.00K | 0.0% |
| Q2 FY2022 | Jun 30, 2022 | $57.00K | 0.0% |
| Q1 FY2022 | Mar 31, 2022 | $56.00K | 0.0% |
| Q4 FY2021 | Dec 31, 2021 | $56.00K | -1.8% |
| Q3 FY2021 | Sep 30, 2021 | $57.00K | -13.6% |
| Q2 FY2021 | Jun 30, 2021 | $57.00K | +1.8% |
| Q1 FY2021 | Mar 31, 2021 | $56.00K | +7.7% |
| Q4 FY2020 | Dec 31, 2020 | $57.00K | +90.0% |
| Q3 FY2020 | Sep 30, 2020 | $66.00K | +4.8% |
| Q2 FY2020 | Jun 30, 2020 | $56.00K | -97.2% |
| Q1 FY2020 | Mar 31, 2020 | $52.00K | -23.5% |
| Q4 FY2019 | Dec 31, 2019 | $30.00K | -49.2% |
| Q3 FY2019 | Sep 30, 2019 | $63.00K | -47.5% |
| Q2 FY2019 | Jun 30, 2019 | $2.02M | +316.9% |
| Q1 FY2019 | Mar 31, 2019 | $68.00K | -87.9% |
| Q4 FY2018 | Dec 31, 2018 | $59.00K | -58.7% |
| Q3 FY2018 | Sep 30, 2018 | $120.00K | +9.1% |
| Q2 FY2018 | Jun 30, 2018 | $485.00K | +49.7% |
| Q1 FY2018 | Mar 31, 2018 | $564.00K | +168.6% |
| Q4 FY2017 | Dec 31, 2017 | $143.00K | -17.3% |
| Q3 FY2017 | Sep 30, 2017 | $110.00K | -93.3% |
| Q2 FY2017 | Jun 30, 2017 | $324.00K | – |
| Q1 FY2017 | Mar 31, 2017 | $210.00K | – |
| Q4 FY2016 | Dec 31, 2016 | $173.00K | – |
| Q3 FY2016 | Sep 30, 2016 | $1.65M | – |
See a number that looks wrong?